MYC and neoplasm: Nonetheless, we propose that combining inhibitors of cathepsin L with other factors targeting tumor cell autophagy may have therapeutic potential for Myc-driven malignancies at advanced stages of progression, when autophagy evidently becomes important for sustaining robust cell proliferation and tumor growth.